US Patent 7709526 Use of cyclolignans and new cyclolignans

Patent 7709526 was granted and assigned to Swedish Orphan Biovitrum on May, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Swedish Orphan Biovitrum

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

77095260

Patent Inventor Names

Magnus Axelson0

Olle Larsson0

Date of Patent

May 4, 2010

Patent Application Number

113462940

Date Filed

February 3, 2006

Patent Primary Examiner

‌

Janet L. Andres

Patent abstract

Compounds which inhibit the insulin-like growth factor-1 receptor (IGF-1 R) and methods for using them for treating IGF-1 R dependent diseases, such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7709526 Use of cyclolignans and new cyclolignans

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API